Europe Markets: European stocks edge back from record high as key U.S. report looms

Previous article

: Biogen’s pivotal moment: Will the FDA approve the experimental — and controversial — Alzheimer’s-disease drug aducanumab?

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *